⌘K
t
NatWest Group plc purchased a total of 782,352 ordinary shares from UBS AG, London Branch on 23 February 2026, with transaction prices ranging from a lowest of 607.20 GBp to a highest of 622.20 GBp. These purchases formed part of the company's existing share buyback programme, and NatWest Group plc intends to cancel the repurchased shares. Following the settlement, the company holds 217,946,642 ordinary shares in treasury and has 7,978,074,610 ordinary shares in issue (excluding treasury shares).
| Date | 23 Feb 2026 |
| Time | 18:09:18 |
| Category | Capital structure |
| ID | 0768U |
|
NatWest Group plc |
||||||
|
23 February 2026 |
|
|||||
|
Transaction in Own Shares |
||||||
|
NatWest Group plc (the 'Company') announces today that it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ('Ordinary Shares') from UBS AG, London Branch ('UBS'). |
|
|||||
|
|
|
|
|
|
|
|
|
Aggregated information: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of purchase |
Number of Ordinary Shares purchased |
Highest price paid: (GBp) |
Lowest price paid: (GBp) |
Volume weighted average price paid per share (GBp) |
Venue |
|
|
23 February 2026 |
611,042 |
622.20 |
607.20 |
613.65 |
LSE |
|
|
23 February 2026 |
119,575 |
621.80 |
607.40 |
614.83 |
CHIX |
|
|
23 February 2026 |
51,735 |
621.60 |
608.60 |
614.93 |
BATE |
|
|
|
|
|
|
|
|
|
|
* Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share |
|
|||||
|
Such purchases form part of the Company's existing share buyback programme and were effected pursuant to the instructions issued by the Company to UBS on 16 February 2026, as announced on 16 February 2026. |
|
|||||
|
|
|
|
|
|
|
|
|
The Company intends to cancel the repurchased Ordinary Shares. |
||||||
|
|
|
|
|
|
|
|
|
Following the settlement of the above transactions, NWG will hold 217,946,642 Ordinary Shares in treasury and have 7,978,074,610 Ordinary Shares in issue (excluding treasury shares). |
|
|||||
|
|
|
|
|
|
|
|
|
Further information: |
||||||
|
|
|
|
|
|
|
|
|
Investor Relations |
|
|
|
|
|
|
|
+ 44 (0)207 672 1758 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Media Relations |
|
|
|
|
|
|
|
+44 (0)131 523 4205 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Legal Entity Identifier: 2138005O9XJIJN4JPN90 |
||||||
|
|
|
|
|
|
|
|
|
Transaction details: |
|
|
|
|
|
|
|
In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf of the Company as part of the buyback programme relating to the Transactions is detailed in the attached: |
|
|||||
| http://www.rns-pdf.londonstockexchange.com/rns/0768U_1-2026-2-23.pdf | ||||||
|
|
|
|
|
|
|
|